Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by wagyusteakon Aug 13, 2020 10:15am
129 Views
Post# 31402811

RE:RE:RE:Nothing Fine

RE:RE:RE:Nothing Fine
fdfd12 wrote: Check SEDAR nothing is adjusted. They are playing with words.
Please check Sedar where you will have the full numbers.

Last Q, they had to deduct about 1M so EPS was negative.
This Q, they added 16.5M so we got .13.

Check SEDAR please


wagyusteak wrote:
fdfd12 wrote:
They had a gain of $16.5 M which was a one time gain.
Without that, they would have a LOSS again.
Please check it out on SEDAR



that was adjusted in the CFO. check the cash flows statement. Non-cash operating items have been adjusted





dude, you have to look at the cash flow statement to see the actual cash going in and coming out. Financial assets fluctions affect the earnings result which makes it less meaningful. Samething for berkshire. Look at the cash flow statement. they deducted $16.5mil and got POSITIVE $8mil cash inflow
Bullboard Posts